Table 2

Association between individual KIRs and progression-free survival on univariate analysis

KIR geneFrequency in patient sample (%)P*
KIR2DL1 171 (94) .999 
KIR2DL2 98 (53.6) .97 
KIR2DL3 151 (89) .046 
KIR2DL4 177 (97) .999 
KIR2DL5A (Alleles 001/005) 55 (30) .019 
KIR2DL5B (Alleles 002-004, 006/007 45 (25) .93 
KIR3DL1 167 (92) .999 
KIR3DL2 177 (97) .999 
KIR3DL3 173 (95) .999 
KIR2DS1 51 (28) .041 
KIR2DS2 95 (52) .32 
KIR2DS3 47 (26) .13 
KIR2DS4 (alleles: 0010101-0010103, 00102/002) 82 (45) .38 
KIR2DS4 (alleles 003/004/006/007) 139 (76) .385 
KIR2DS5 55 (30) .31 
KIR3DS1 62 (34) .01 
KIR2DP1 180 (99) .999 
KIR3DP1 180 (99) .999 
KIR geneFrequency in patient sample (%)P*
KIR2DL1 171 (94) .999 
KIR2DL2 98 (53.6) .97 
KIR2DL3 151 (89) .046 
KIR2DL4 177 (97) .999 
KIR2DL5A (Alleles 001/005) 55 (30) .019 
KIR2DL5B (Alleles 002-004, 006/007 45 (25) .93 
KIR3DL1 167 (92) .999 
KIR3DL2 177 (97) .999 
KIR3DL3 173 (95) .999 
KIR2DS1 51 (28) .041 
KIR2DS2 95 (52) .32 
KIR2DS3 47 (26) .13 
KIR2DS4 (alleles: 0010101-0010103, 00102/002) 82 (45) .38 
KIR2DS4 (alleles 003/004/006/007) 139 (76) .385 
KIR2DS5 55 (30) .31 
KIR3DS1 62 (34) .01 
KIR2DP1 180 (99) .999 
KIR3DP1 180 (99) .999 

Distribution of KIR in the study population is presented.

*

P for significance on PFS on univariate analysis.

Values statistically significant.

Close Modal

or Create an Account

Close Modal
Close Modal